Literature DB >> 33706908

Fertility Considerations in Pediatric and Adolescent Patients Undergoing Cancer Therapy.

Timothy B Lautz1, Karen Burns2, Erin E Rowell3.   

Abstract

Survivors of pediatric cancer are at increased risk for infertility and premature hormonal failure. Surgeons caring for children with cancer have an important role to play in understanding this risk, as well as advocating for and performing appropriate fertility preservation procedures. Fertility preservation options in males and females vary by pubertal status and include nonexperimental (oocyte harvest, ovarian tissue cryopreservation, sperm cryopreservation) and experimental (testicular tissue cryopreservation) options. This review summarizes the basics of risk assessment and fertility preservation options and explores unique considerations in pediatric fertility preservation.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; Fertility preservation; Infertility; Pediatric; Survivorship

Year:  2021        PMID: 33706908     DOI: 10.1016/j.soc.2020.11.009

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  2 in total

1.  International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines.

Authors:  Simone de Campos Vieira Abib; Chan Hon Chui; Sharon Cox; Abdelhafeez H Abdelhafeez; Israel Fernandez-Pineda; Ahmed Elgendy; Jonathan Karpelowsky; Pablo Lobos; Marc Wijnen; Jörg Fuchs; Andrea Hayes; Justin T Gerstle
Journal:  Ecancermedicalscience       Date:  2022-02-17

2.  Analysis of Fertility Preservation by Ovarian Tissue Cryopreservation in Pediatric Children in China.

Authors:  Xiangyan Ruan; Jiaojiao Cheng; Juan Du; Fengyu Jin; Muqing Gu; Yanglu Li; Rui Ju; Yurui Wu; Huanmin Wang; Wei Yang; Haiyan Cheng; Long Li; Wenpei Bai; Weimin Kong; Xin Yang; Shulan Lv; Yuejiao Wang; Yu Yang; Xin Xu; Lingling Jiang; Yanqiu Li; Alfred O Mueck
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-29       Impact factor: 6.055

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.